8900 N Kendall Dr# MiamiMiami, FL 33176
Fax+1 305-279-7778
Overview of Dr. Manoharan
Dr. M. Manoharan MD, FRCS(Eng), FRACS(Urol) is the "Chief of Urologic Oncology and the Director of Robotic Urologic Surgery" at the "Miami Cancer Institute, Baptist Health South Florida, Miami, USA ". He is internationally known for his expertise in Urologic Oncology, Robotic surgery, Neobladder reconstruction and other urinary reconstruction . He has served a member in the International bladder cancer guidelines committee. He has delivered several lectures in both national and international scientific meetings and conducted urological workshops. He has published more than 140 articles in peer reviewed journals and authored 15 text book chapters. He is an active investigator in several Urologic Oncology research studies. He completed his urology training in New Zealand and Urologic Oncology training at University of Miami.
Clinical Expertise
- Minimally invasive urologic surgery, Urologic oncology, Robotic surgery, laparoscopic surgery, urologic oncology, reconstruction, Robotic prostatectomy, Orthotopic bladder substitution, Robotic partial nephrectomy, Robotic nephrectomy, Radical cystectomy, Lymphadenectomy, Ureteral reconstruction, Ileal conduit, Ben ign prostatic hyperplasia, Greenlight laser therapy for benign prostatic hyperplasia, Urethral cancer, Micropapillary carcinoma
Education & Training
University of Miami Hospital and ClinicsFellowship, Urologic Surgical Oncology, 2002 - 2003
Madras Medical CollegeClass of 1988
Certifications & Licensure
FL State Medical License 2003 - 2027
IN State Medical License 2005 - 2017
IA State Medical License 2005 - 2015
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2016
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2016
Clinical Trials
- Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
- Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Start of enrollment: 2016 Jan 05
- MRI Based Active Selection for Treatment Trial Start of enrollment: 2014 Nov 12
Publications & Presentations
PubMed
- Metastatic non-muscle invasive bladder cancer: histology-specific metastatic patterns and survival in a national cancer database analysis.Mohamed Javid Raja Iyub, Pushan Prabhakar, Deerush Kannan Sakthivel, Aditi Chandrasekaran, Manuel Ozambela Jr
International Urology and Nephrology. 2026-05-01 - CLO26-099: Impact of Comorbidity Burden on Functional and Oncologic Outcomes Following Nerve-Sparing Robotic Radical Prostatectomy.Deerush Kannan Sakthivel, Pushan Prabhakar, Mohamed Javid Raja Iyub, Anika Venugopal, Manuel Ozambela Jr
Journal of the National Comprehensive Cancer Network. 2026-03-31 - CLO26-118: Postoperative Ileus Following Radical Cystectomy: Incidence and Risk Factors in Current Urological Practice.Mohamed Javid Raja Iyub, Pushan Prabhakar, Arjun Pon Avudaiappan, Deerush Kannan Sakthivel, Jose Manuel Hernandez Gutierrez
Journal of the National Comprehensive Cancer Network. 2026-03-31
Press Mentions
The Challenges with Using Targeted Therapies in Ovarian Cancer SpaceMarch 25th, 2023- New Technology Leads to More Accurate Prostate Cancer Diagnosis and TreatmentsMay 24th, 2021
Miami Cancer Institute Names Murugesan Manoharan, as Chief of Urologic Oncology SurgeryFebruary 19th, 2017
Professional Memberships
- Member
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
